MarieGriffinMD

Preventive Medicine

Professor, Preventive Medicine, Vanderbilt University School of Medicine

Dr. Griffin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1985
Emory University School of MedicineResidency, Internal Medicine, 1977 - 1979
Georgetown University School of MedicineClass of 1976

TN State Medical License 1986 - 2022
MD State Medical License 1981 - 1986
MN State Medical License 1983 - 1985
GA State Medical License 1978 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Preventive Medicine Public Health & General Preventive Medicine

Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015

PubMed

1 citations
Postmarketing Vaccine Safety Assessments: Important Work in Progress.
Kathryn M Edwards, Marie R Griffin
JAMA. 2024-03-19
2 citations
Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children.
Leigh M Howard, Xiang Huang, Wencong Chen, Yuhan Liu, Kathryn M Edwards
International Journal of Infectious Diseases. 2023-09-01
Monitoring Multiple U.S. Government-Supported Covid-19 Vaccine Trials.
Sally Hunsberger, Susan S Ellenberg, Steven Joffe, Abdel Babiker, Alan Fix
NEJM Evidence. 2023-03-01

Journal Articles

Recent Metformin Adherence and the Risk of Hypoglycaemia in the Year Following Intensification with a Sulfonylurea
C L Roumie, M R Griffin, A M Hung, Diabetic Medicine
Trends in High-Grade Cervical Lesions and Cervical Cancer Screening in Five States, 2008–2015
Marie R Griffin, Lauri E Markowitz, Nancy M Bennett, Ina U Park, Elizabeth R Unger, Clinical Infectious Diseases

F.D.A. Panel Recommends 2 R.S.V. Vaccines for Older AdultsMarch 1st, 2023
FDA Advisers Narrowly Vote in Favor of Pfizer’s RSV Vaccine for Older Adults, Despite Possible Safety ConcernsFebruary 28th, 2023
COVID-19 Contact Tracing in Chattanooga Area Becomes Harder as People Distance LessJune 28th, 2020
Join now to see all